Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change -0.09
Percentage change -3.77	%

Peers: NTLA CRSP EDIT BEAM FDMT IOBT SGMO CLLS DTIL CYTK

| Held by: XBI IWM VTI VXF IWN IBB SCHA DFAS VTWO DFAT

Index	RUT	P/E	-	EPS (ttm)	-1.56	Insider Own	35.76%	Shs Outstand	209.50M	Perf Week	53.90%
Market Cap	454.99M	Forward P/E	-	EPS next Y	-1.35	Insider Trans	-0.20%	Shs Float	134.69M	Perf Month	13.02%
Income	-283.43M	PEG	-	EPS next Q	-0.33	Inst Own	65.95%	Short Float	23.79%	Perf Quarter	0.93%
Sales	0.04M	P/S	11374.75	EPS this Y	36.25%	Inst Trans	-1.04%	Short Ratio	6.30	Perf Half Y	-17.80%
Book/sh	2.21	P/B	0.98	EPS next Y	-1.65%	ROA	-43.56%	Short Interest	32.05M	Perf Year	-53.33%
Cash/sh	1.39	P/C	1.56	EPS next 5Y	11.41%	ROE	-54.15%	52W Range	1.32 - 5.78	Perf YTD	1.88%
Dividend Est.	-	P/FCF	-	EPS past 5Y	22.18%	ROI	-51.64%	52W High	-62.42%	Beta	1.05
Dividend TTM	-	Quick Ratio	9.35	Sales past 5Y	-34.74%	Gross Margin	-32186.05%	52W Low	64.39%	ATR (14)	0.35
Dividend Ex-Date	-	Current Ratio	9.35	EPS Y/Y TTM	30.29%	Oper. Margin	-625246.51%	RSI (14)	55.15	Volatility	38.09% 15.08%
Employees	233	Debt/Eq	0.20	Sales Y/Y TTM	-	Profit Margin	-659137.21%	Recom	1.56	Target Price	9.96
Option/Short	Yes / Yes	LT Debt/Eq	0.18	EPS Q/Q	13.34%	Payout	-	Rel Volume	0.96	Prev Close	2.26
Sales Surprise	-83.33%	EPS Surprise	3.85%	Sales Q/Q	-100.00%	Earnings	Nov 07 AMC	Avg Volume	5.09M	Price	2.17
SMA20	17.22%	SMA50	10.46%	SMA200	-11.70%	Trades		Volume	4,874,058	Change	-3.77%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-08-24	Resumed	Oppenheimer	Outperform	$13 → $11
May-31-24	Initiated	Piper Sandler	Overweight	$11
Jan-05-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jan-05-24	Downgrade	Guggenheim	Buy → Neutral
Dec-08-23	Initiated	Citigroup	Buy	$7
Dec-08-23	Initiated	Citigroup	Buy
Jun-26-23	Resumed	Oppenheimer	Outperform	$28
Mar-21-23	Initiated	Bernstein	Mkt Perform	$6
Jan-24-23	Upgrade	JP Morgan	Neutral → Overweight	$20 → $11
Jan-06-23	Upgrade	Robert W. Baird	Neutral → Outperform	$12
Dec-12-22	Downgrade	BofA Securities	Buy → Underperform	$24 → $9
Aug-10-22	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-15-22	Upgrade	Goldman	Neutral → Buy	$9 → $32
Jun-03-22	Initiated	Robert W. Baird	Neutral	$11
Feb-28-22	Reiterated	B. Riley Securities	Buy	$30 → $21
Oct-20-21	Initiated	Cowen	Outperform
Oct-08-21	Downgrade	Stifel	Buy → Hold	$44 → $18
Oct-08-21	Downgrade	Goldman	Buy → Neutral	$71 → $20
Sep-23-21	Upgrade	Raymond James	Mkt Perform → Outperform
Jun-21-21	Resumed	Jefferies	Buy	$53

Show Previous Ratings

Feb-13-25 04:30PM	Allogene Therapeutics Announces Publication of Durable Response Data from Phase 1 ALPHA/ALPHA2 Trials of the Allogeneic CAR T Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma in the Journal of Clinical Oncology (GlobeNewswire) +44.68%
Feb-04-25 08:30AM	Allogene Therapeutics Announces Participation in February Investor Conferences (GlobeNewswire)
Jan-29-25 08:30AM	Allogene Therapeutics Announces Benjamin M. Beneski as Senior Vice President and Chief Technical Officer (GlobeNewswire)
Jan-28-25 08:30AM	Allogene Therapeutics Secures U.S. FDA IND Clearance for ALLO-329, Advancing its Next-Generation Allogeneic CAR T into Autoimmune Diseases (GlobeNewswire)
Dec-26-24 12:00PM	Allogene Therapeutics (ALLO) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
11:26AM	Loading…
11:26AM	Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment (PR Newswire)
Dec-16-24 08:30AM	Allogene Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +8.99%
Dec-12-24 08:30AM	Allogene Therapeutics Acknowledges the Passing of Founding Board Member David Bonderman (GlobeNewswire) -5.61%
Nov-25-24 12:00PM	Allogene Therapeutics (ALLO) Upgraded to Buy: Here's Why (Zacks)
Nov-19-24 08:30AM	Allogene Therapeutics Announces Participation in December Investor Conferences (GlobeNewswire)
Nov-18-24 08:30AM	Allogene Therapeutics Presents Preclinical Data for ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Disease at the American College of Rheumatology (ACR) Convergence (GlobeNewswire) -5.29%
Nov-08-24 06:07AM	Allogene Therapeutics Inc (ALLO) Q3 2024 Earnings Call Highlights: Financial Resilience Amidst ... (GuruFocus.com)
Nov-07-24 04:11PM	Allogene Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
04:02PM	Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update (GlobeNewswire)
10:00AM	Allogene Therapeutics Announces Positive Phase 1 Data Demonstrating the Potential of ALLO-316 in Heavily Pretreated Patients with Advanced Renal Cell Carcinoma at SITC and IKCS (GlobeNewswire)
07:31AM	Loading…
Nov-06-24 07:31AM	Allogene Therapeutics Inc (ALLO) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +7.69%
Nov-05-24 09:10AM	Allogene Therapeutics to Present New Data Demonstrating the Potential of ALLO-316 in Heavily Pretreated Adult Patients with CD70 Positive Advanced Renal Cell Carcinoma (RCC) at the International Kidney Cancer Symposium (IKCS) and Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire)
Nov-04-24 08:30AM	Allogene Therapeutics Announces Participation in November Investor Conferences (GlobeNewswire) +10.29%
Oct-31-24 10:01AM	Will Allogene Therapeutics (ALLO) Report Negative Earnings Next Week? What You Should Know (Zacks)
Oct-30-24 08:30AM	Allogene Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update (GlobeNewswire) -5.71%
Oct-29-24 08:30AM	Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ALLO-316, an AlloCAR T Investigational Product for Adult Patients with Advanced or Metastatic Renal Cell Carcinoma (RCC) (GlobeNewswire)
Oct-22-24 04:05PM	Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors (GlobeNewswire)
Oct-03-24 07:19AM	Allogene Therapeutics, Inc. (ALLO): Among the Rising Penny Stocks to Invest In Now (Insider Monkey)
Sep-30-24 08:30AM	Allogene Therapeutics Announces Participation in the Goldman Sachs Cell Therapy Day Conference (GlobeNewswire)
Sep-26-24 08:30AM	Allogene Therapeutics to Present Pre-Clinical Data Highlighting the Potential of ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Diseases, at the American College of Rheumatology (ACR) Convergence (GlobeNewswire)
Sep-14-24 05:39PM	Allogene Therapeutics, Inc. (ALLO): Short Seller Sentiment is Bearish on This Cancer Stock (Insider Monkey)
Sep-06-24 11:31AM	Allogene Therapeutics (ALLO) Up 6.4% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-08-24 09:50AM	Allogene (ALLO) Posts Narrower Than Expected Loss in Q2 (Zacks)
08:30AM	Allogene Therapeutics Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
06:00AM	7 Biotech Stocks to Buy for Their Game-Changing Potential (InvestorPlace)
04:10PM	Loading…
Aug-07-24 04:10PM	Allogene Therapeutics: Q2 Earnings Snapshot (Associated Press Finance)
04:02PM	Allogene Therapeutics Reports Second Quarter 2024 Financial Results and Business Update (GlobeNewswire)
Jul-31-24 08:30AM	Allogene Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update (GlobeNewswire)
Jul-01-24 08:30AM	Allogene Therapeutics Activates Three Community Cancer Centers as First Sites for the Pivotal Phase 2 ALPHA3 Trial Evaluating Cemacabtagene Ansegedleucel (cema-cel) as First Line (1L) Consolidation Treatment for Patients with Large B-Cell Lymphoma (LBCL) (GlobeNewswire)
Jun-27-24 10:13AM	Allogene Therapeutics, Inc. (ALLO): Are Analysts Bullish About the Potential of This Small-Cap Stock? (Insider Monkey)
Jun-26-24 04:36PM	Top 10 Small-Cap Stocks with Highest Upside Potential (Insider Monkey)
Jun-20-24 08:30AM	Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse (GlobeNewswire) +9.42%
Jun-12-24 11:30AM	Allogene Therapeutics (ALLO) Down 13.9% Since Last Earnings Report: Can It Rebound? (Zacks)
May-29-24 08:55AM	Insiders Pour Millions Into These 2 Strong Buy Stocks (TipRanks)
May-28-24 04:05PM	If You Can Only Buy One Penny Stock in May, It Better Be One of These 3 Names (InvestorPlace)
May-23-24 08:30AM	Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit (GlobeNewswire)
May-21-24 01:56PM	Hedge Fund and Insider Trading News: Ken Griffin, Sanjay Shah, David Tepper, Stanley Druckenmiller, Michael Burry, Cevian Capital, Elliott Management, Millennium Management, Eisler Capital, Allogene Therapeutics Inc (ALLO), Carvana Co. (CVNA) and More (Insider Monkey)
08:16AM	Oppenheimer Trims Allogene Therapeutics Price Target to $13 From $14, Maintains Outperform Rating (MT Newswires)
May-16-24 08:13AM	HC Wainwright Adjusts Price Target on Allogene Therapeutics to $9 From $10, Keeps Buy Rating (MT Newswires)
May-14-24 12:56PM	Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag (Zacks)
09:14AM	Stifel Adjusts Price Target on Allogene Therapeutics to $4.60 From $4.40, Keeps Hold Rating (MT Newswires)
08:21AM	B. Riley Adjusts Price Target on Allogene Therapeutics to $7 From $10, Keeps Buy Rating (MT Newswires)
03:06AM	Allogene Therapeutics Inc (ALLO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com)
May-13-24 08:55PM	ALLO Stock Earnings: Allogene Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +5.07%
05:36PM	Allogene Therapeutics Prices $110 Million Offering (MT Newswires)
05:10PM	Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:47PM	Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock (GlobeNewswire)
04:17PM	Allogene Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
04:14PM	Allogene Therapeutics Q1 Loss Narrows, Revenue Declines (MT Newswires)
04:01PM	Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update (GlobeNewswire)
May-06-24 08:30AM	Allogene Therapeutics to Report First Quarter Financial Results and Provide Business Update (GlobeNewswire)
Apr-26-24 10:32AM	Allogene Therapeutics Gets $15 Million Grant from California Institute for Regenerative Medicine for Cancer Drug Development (MT Newswires)
08:30AM	Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma (GlobeNewswire)
Apr-24-24 10:01AM	Allogene Therapeutics (ALLO) Expected to Beat Earnings Estimates: Should You Buy? (Zacks) -9.79%
Apr-11-24 02:45PM	3 Meme Stocks to Sell and Replace With Meme Coins (InvestorPlace)
Apr-09-24 08:30AM	Allogene Therapeutics Announces Q2 Investor Conference Participation (GlobeNewswire)
Apr-08-24 08:46AM	How Allogene (ALLO) Stock Stands Out in a Strong Industry (Zacks)
Mar-16-24 04:35PM	Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-15-24 09:32AM	Allogene's (ALLO) Q4 Loss Narrower Than Expected, Sales Miss (Zacks)
07:04AM	Q4 2023 Allogene Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-14-24 08:55PM	ALLO Stock Earnings: Allogene Therapeutics Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) -7.89%
05:34PM	Allogene Therapeutics Inc (ALLO) Reports Q4 and Full Year 2023 Financials, Forecasts Cash ... (GuruFocus.com)
05:15PM	Allogene Therapeutics (ALLO) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:15PM	Allogene Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update (GlobeNewswire)
Mar-13-24 12:15PM	Allogene (ALLO) Inks Deal With Arbor Bio for CRISPR Technology (Zacks)
Mar-12-24 08:50AM	Allogene taps Arbor in pursuit of off-the-shelf CAR-T therapies for autoimmune disease (BioPharma Dive)
08:30AM	Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease (GlobeNewswire)
Mar-05-24 09:55AM	Allogene Therapeutics (ALLO)'s Technical Outlook is Bright After Key Golden Cross (Zacks)
08:30AM	Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update (GlobeNewswire)
Feb-28-24 08:30AM	Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference (GlobeNewswire)
Feb-16-24 08:30AM	Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia (GlobeNewswire)
Jan-16-24 04:05PM	Allogene Therapeutics Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
Jan-12-24 08:34AM	How Allogene (ALLO) Stock Stands Out in a Strong Industry (Zacks)
Jan-05-24 12:52PM	Allogene (ALLO) Down 20% on Strategic Changes in Pipeline (Zacks) -14.01%
08:25AM	UPDATE 2-Allogene to cut 22% of its workforce (Reuters)
08:13AM	Allogene to cut 22% of its workforce (Reuters)
Jan-04-24 04:15PM	Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma (GlobeNewswire)
04:05PM	Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma (GlobeNewswire)
11:05AM	Allogene to shift strategy in bid to reposition CAR-T (BioPharma Dive)
Jan-03-24 04:05PM	Allogene Therapeutics to Host Conference Call Previewing its 2024 Platform Vision and Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -8.01%
Dec-09-23 12:00PM	Allogene Therapeutics Presents Comprehensive Safety Data of Proprietary Lymphodepletion Agent ALLO-647 at the 65th Annual Meeting of the American Society of Hematology (GlobeNewswire)
Dec-01-23 08:30AM	Allogene Therapeutics Announces Participation in December Investor Conference (GlobeNewswire) +7.23%
Nov-24-23 06:40AM	7 Penny Stocks With Low Floats and High Short Interest (InvestorPlace)
Nov-10-23 12:00PM	Allogene Therapeutics (ALLO) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
Nov-03-23 12:15PM	Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q3 2023 Earnings Call Transcript (Insider Monkey) +17.85%
12:00PM	Allogene Therapeutics Presents Preclinical Data on Next Generation Cloak and Dagger Technologies at the Society for Immunotherapy of Cancer Annual Meeting (GlobeNewswire)
12:00PM	Allogene Therapeutics Presents Preclinical Data on a Novel Allogeneic CAR T Product Candidate Targeting Claudin18.2 at the Society for Immunotherapy of Cancer Annual Meeting (GlobeNewswire)
10:15AM	Allogene's (ALLO) Q3 Loss Narrower Than Expected, Sales Miss (Zacks)
Nov-02-23 07:33PM	Allogene Therapeutics Inc (ALLO) Reports Q3 2023 Financial Results (GuruFocus.com)
04:12PM	Allogene Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
04:02PM	Allogene Therapeutics Reports Third Quarter 2023 Financial Results and Business Update (GlobeNewswire)
09:00AM	Allogene Therapeutics Announces Poster Presentations at the 65th Annual Meeting of the American Society of Hematology (GlobeNewswire)
Oct-30-23 08:30AM	Allogene Therapeutics Announces Participation in November Investor Conferences (GlobeNewswire) +9.09%
Oct-26-23 08:30AM	Allogene Therapeutics to Report Third Quarter 2023 Financial Results on November 2, 2023 (GlobeNewswire)

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, David M. Tanen, and Joshua A. Kazam in November 2017 and is headquartered in South San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MESSEMER DEBORAH M.	Director	Feb 18 '25	Sale	2.43	13,313	32,351	144,316	Feb 20 04:15 PM
MESSEMER DEBORAH M.	Director	Feb 18 '25	Proposed Sale	2.43	13,313	32,329		Feb 18 05:27 PM
Douglas Earl Martin	SVP, General Counsel	Feb 03 '25	Sale	1.71	6,404	10,951	587,848	Feb 05 04:16 PM
Parker Geoffrey M.	CHIEF FINANCIAL OFFICER	Feb 03 '25	Sale	1.73	4,361	7,545	1,301,540	Feb 05 04:15 PM
MOORE TIMOTHY L.	Chief Technical Officer	Feb 03 '25	Sale	1.71	14,746	25,216	250,713	Feb 05 04:14 PM
Chang David D	President and CEO	Feb 03 '25	Sale	1.68	46,003	77,285	5,317,237	Feb 05 04:13 PM
Roberts Zachary	EVP of R&D	Feb 03 '25	Sale	1.70	18,832	32,014	643,135	Feb 05 04:12 PM
Roberts Zachary	Officer	Feb 03 '25	Proposed Sale	1.70	18,832	32,014		Feb 03 04:32 PM
Chang David D	Officer	Feb 03 '25	Proposed Sale	1.68	46,003	77,446		Feb 03 04:31 PM
Douglas Earl Martin	Officer	Feb 03 '25	Proposed Sale	1.71	6,404	10,951		Feb 03 04:30 PM
MOORE TIMOTHY L.	Officer	Feb 03 '25	Proposed Sale	1.71	14,746	25,225		Feb 03 04:29 PM
Parker Geoffrey M.	Officer	Feb 03 '25	Proposed Sale	1.73	4,361	7,545		Feb 03 04:28 PM
Roberts Zachary	EVP of R&D	Jan 21 '25	Sale	1.78	27,199	48,414	488,054	Jan 23 04:30 PM
Roberts Zachary	Officer	Jan 21 '25	Proposed Sale	1.78	27,199	48,499		Jan 21 04:22 PM
MESSEMER DEBORAH M.	Director	Dec 09 '24	Sale	2.18	9,136	19,916	157,629	Dec 10 04:53 PM
Humer Franz B	Director	Dec 05 '24	Sale	2.16	9,221	19,917	307,507	Dec 09 04:05 PM
MESSEMER DEBORAH M.	Director	Dec 09 '24	Proposed Sale	2.18	9,136	19,954		Dec 09 04:02 PM
Humer Franz B	Director	Dec 03 '24	Proposed Sale	2.48	9,221	22,868		Dec 02 02:11 PM
Parker Geoffrey M.	Officer	Oct 21 '24	Proposed Sale	2.84	36,404	103,501		Oct 21 04:05 PM
Douglas Earl Martin	Officer	Aug 21 '24	Proposed Sale	2.79	28,310	78,844		Aug 21 04:18 PM
MESSEMER DEBORAH M.	Director	Jun 18 '24	Sale	2.28	18,641	42,488	166,765	Jun 20 04:31 PM
Humer Franz B	Director	May 30 '24	Sale	2.34	11,200	26,181	255,253	Jun 03 04:09 PM
Belldegrun Arie	Director	May 16 '24	Buy	2.90	1,724,137	4,999,997	1,724,137	May 20 09:33 PM

Open in Screener

TPG

TPG Inc

Feb 21 • 04:00PM ET

56.63

Dollar change -1.87
Percentage change -3.20	%

Financial • Asset Management • USA • NASD

Peers: BX KKR CG APO ARES HLNE BXMT MAIN OCSL GAIN

| Held by: VTI VB VBR VXF FXO SCHA VYM IWR FPX PSP

Index	-	P/E	-	EPS (ttm)	-0.42	Insider Own	16.08%	Shs Outstand	109.21M	Perf Week	-3.18%
Market Cap	20.92B	Forward P/E	17.96	EPS next Y	3.15	Insider Trans	-0.00%	Shs Float	81.78M	Perf Month	-17.34%
Income	0.36M	PEG	-	EPS next Q	0.53	Inst Own	89.21%	Short Float	4.67%	Perf Quarter	-14.75%
Sales	3.50B	P/S	5.98	EPS this Y	17.69%	Inst Trans	0.77%	Short Ratio	3.63	Perf Half Y	16.69%
Book/sh	7.18	P/B	7.89	EPS next Y	30.72%	ROA	0.00%	Short Interest	3.82M	Perf Year	31.21%
Cash/sh	2.22	P/C	25.48	EPS next 5Y	21.27%	ROE	0.05%	52W Range	39.18 - 72.98	Perf YTD	-9.88%
Dividend Est.	2.11 (3.73%)	P/FCF	-	EPS past 5Y	-	ROI	0.02%	52W High	-22.40%	Beta	1.47
Dividend TTM	2.18 (3.85%)	Quick Ratio	-	Sales past 5Y	30.26%	Gross Margin	96.13%	52W Low	44.54%	ATR (14)	2.18
Dividend Ex-Date	Feb 21, 2025	Current Ratio	-	EPS Y/Y TTM	-98.56%	Oper. Margin	0.15%	RSI (14)	27.31	Volatility	3.61% 3.28%
Employees	1900	Debt/Eq	2.02	Sales Y/Y TTM	46.69%	Profit Margin	0.01%	Recom	2.07	Target Price	70.50
Option/Short	Yes / Yes	LT Debt/Eq	1.87	EPS Q/Q	-256.95%	Payout	-	Rel Volume	2.72	Prev Close	58.50
Sales Surprise	-1.36%	EPS Surprise	18.64%	Sales Q/Q	9.64%	Earnings	Feb 11 BMO	Avg Volume	1.05M	Price	56.63
SMA20	-10.21%	SMA50	-12.34%	SMA200	1.72%	Trades		Volume	2,852,191	Change	-3.20%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-12-24	Initiated	Wells Fargo	Overweight	$60
May-10-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$43 → $52
Jan-04-24	Initiated	TD Cowen	Market Perform	$38
Dec-06-23	Resumed	BMO Capital Markets	Market Perform	$36
Nov-30-23	Resumed	Goldman	Buy	$43
May-19-23	Initiated	Citigroup	Buy	$32
Jan-24-23	Downgrade	JP Morgan	Overweight → Neutral	$35 → $34
Oct-19-22	Initiated	Credit Suisse	Neutral	$27.50
Oct-17-22	Initiated	Jefferies	Hold	$30
Oct-14-22	Downgrade	Exane BNP Paribas	Outperform → Neutral	$32
Jun-08-22	Initiated	JMP Securities	Mkt Perform

Show Previous Ratings

Feb-12-25 02:11AM	TPG Inc (TPG) Q4 2024 Earnings Call Highlights: Record Distributable Earnings and Strategic ... (GuruFocus.com)
Feb-11-25 08:00AM	TPG Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Feb-10-25 07:10AM	TPG Inc (TPG) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Jan-30-25 08:00AM	TPG to Present at the BofA Securities 2025 Financial Services Conference (Business Wire)
Jan-15-25 04:15PM	TPG Appoints Kathy Elsesser as New Independent Director (Business Wire)
08:00AM	Loading…
08:00AM	TPG to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Investor Call (Business Wire)
Jan-10-25 10:00AM	Venu Sports the proposed sports streaming venture between ESPN, Fox, and Warner Bros. is no more (Yahoo Finance)
Dec-23-24 04:21PM	TPG reportedly in talks to acquire Altus Power: Reuters (Yahoo Finance Video)
Dec-13-24 04:15PM	TPG RE Finance Trust, Inc. Declares Cash Dividend on Common Stock (Business Wire)
Dec-12-24 09:00AM	Climate Tech Funds See Cash Pile Rise to $86 Billion as Investing Slows (Bloomberg)
Dec-11-24 02:40PM	David Bonderman, Private Equity Founder, Dead at 82 (The Wall Street Journal)
Dec-09-24 09:24AM	Heres What Lifted TPG (TPG) By 40% (Insider Monkey)
Dec-06-24 04:15PM	TPG RE Finance Trust, Inc. Declares Cash Dividend on Series C Cumulative Redeemable Preferred Stock (Business Wire)
Dec-03-24 08:55AM	AT&T Outlines Strategy Pledging Over $40B in Buybacks, Dividends (Investopedia)
Nov-29-24 04:12AM	TPG on Verge of Buying Controlling Stake in Asian Flower Business Hasfarm (Bloomberg)
08:00AM	Loading…
Nov-25-24 08:00AM	TPG to Present at the Goldman Sachs 2024 U.S. Financial Services Conference (Business Wire)
Nov-22-24 07:54AM	5 Things to Know Before the Stock Market Opens (Investopedia)
06:11AM	DirecTV Scraps Dish Acquisition as Bondholders Push Back on Satellite-TV Merger (Investopedia)
Nov-13-24 08:00AM	Demopolis Equity Partners Announces Strategic Partnership with TPG (Business Wire)
Nov-12-24 06:42AM	TPG price target raised to $69 from $67 at Deutsche Bank (TipRanks)
Nov-06-24 06:35AM	TPG price target raised to $68 from $67 at Wells Fargo (TipRanks) +11.35%
Nov-04-24 08:00AM	TPG Reports Third Quarter 2024 Results (Business Wire) -6.29%
Oct-29-24 03:38PM	Hilco, TPG in joint venture to acquire struggling retail brands, beginning with... (Chain Store Age)
Oct-24-24 12:00AM	Vinted Secures TPG-Led Secondary Investment at Valuation of 5B, Reflecting Profitable Growth (PR Newswire)
Oct-21-24 03:00PM	TPG Names Recently Established Entertainment Company Initial Group and Acquires Grandview in Partnership with Untitled Entertainment (Business Wire)
Oct-14-24 11:38AM	Bausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid (Investopedia)
Oct-07-24 08:00AM	TPG to Announce Third Quarter 2024 Financial Results and Host Investor Call (Business Wire)
Sep-30-24 04:22PM	DirecTV and Dish have spent years trying to merge. It's finally happening. (Yahoo Finance)
04:01PM	DirecTV To Merge With Dish Network As AT&T Exits Pay-TV Business (Investor's Business Daily)
09:30AM	Creative Planning Announces Strategic Investment from TPG Capital (Business Wire)
08:44AM	Loading…
08:44AM	Satellite Rivals DirecTV, Dish To Merge (Investopedia)
07:53AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:46AM	DirecTV and Dish have spent years trying to merge. It might finally happen. (Yahoo Finance)
07:00AM	DIRECTV to Acquire EchoStar's Video Distribution Business, Including DISH TV and Sling TV (PR Newswire)
06:55AM	Satellite service DirecTV buys rival Dish as it fights the onslaught of streaming services (Associated Press Finance)
06:13AM	TPG to Acquire AT&T's 70% Stake in DIRECTV (Business Wire)
Sep-27-24 01:44PM	EchoStar Stock Soars on Report Dish Close To Merging With DirecTV (Investopedia)
10:00AM	DirecTV, Dish reportedly close to merger deal: BBG (Yahoo Finance Video)
07:00AM	Why Drug Distributors Are Buying Cancer Specialists (The Wall Street Journal)
Sep-26-24 05:00PM	Homrich Berg Announces New Minority Investment Partner TPG Growth (Business Wire)
Sep-16-24 09:05PM	TPG Angelo Gordon, Dream Unlimited Corp., and Stadium Capital Partners to Acquire Dutch Residential Real Estate Portfolio (Business Wire)
Sep-11-24 07:55AM	Douglas Dynamics Completes $64.2 Million Sale-Leaseback Transaction with TPG Angelo Gordon (GlobeNewswire)
Sep-06-24 03:08PM	Bondermans Wildcat Spawns New Hedge Fund, Invests $200 Million (Bloomberg)
Sep-03-24 04:20PM	Sixth Street Buys TPG Partners Stake at $10 Billion Value (Bloomberg)
04:05PM	TPG to Present at the Barclays Global Financial Services Conference (Business Wire)
Aug-23-24 05:46AM	Oaktree Plans to Seek Partner for 3,800 Home Project in Dublin (Bloomberg)
Aug-22-24 09:00AM	TPG-Backed PS to be Acquired by Groupe ADP (Business Wire)
Aug-15-24 01:00AM	EQT Seeks $12.5 Billion for Next Asia Fund, Defying Gloom (Bloomberg)
Aug-06-24 03:39PM	TPG Points to Deal Acceleration Heading Into the Second Half (The Wall Street Journal)
08:00AM	TPG Reports Second Quarter 2024 Results (Business Wire)
Jul-18-24 12:06AM	Director Deborah Messemer Sells 4,089 Shares of TPG Inc (TPG) (GuruFocus.com)
Jul-16-24 04:49AM	Strength Seen in TPG Inc. (TPG): Can Its 5.1% Jump Turn into More Strength? (Zacks)
Jul-10-24 08:00AM	TPG to Announce Second Quarter 2024 Financial Results and Host Investor Call (Business Wire)
Jul-04-24 12:00PM	Upcoming Stock Spinoffs: Should You Pounce or Pass? (InvestorPlace)
Jun-28-24 08:00AM	TPG Establishes New Talent Management and Representation Company to Invest in and Build a Scaled Talent-Centric Business (Business Wire)
07:55AM	BOAT ROCKER SELLS MAJORITY STAKE IN UNTITLED ENTERTAINMENT TO LEADING GLOBAL ALTERNATIVE ASSET MANAGER TPG (PR Newswire)
Jun-17-24 09:30AM	K2 Medical Research and TPG Establish Partnership to Build a Leading Integrated Site Platform (Business Wire)
Jun-08-24 05:30PM	15 Most Advanced Countries in 5G Technology (Insider Monkey)
May-29-24 08:00AM	TPG to Present at the Morgan Stanley U.S. Financials, Payments & CRE Conference (Business Wire)
May-22-24 08:07AM	Full Truck Alliance Co. Ltd. (NYSE:YMM) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 12:54PM	TPG Stock Earnings: TPG Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
09:25AM	TPG Inc. (TPG) Beats Q1 Earnings and Revenue Estimates (Zacks)
08:00AM	TPG Reports First Quarter 2024 Results (Business Wire)
May-02-24 01:00PM	Cencora (NYSE:COR) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-01-24 10:01AM	TPG Inc. (TPG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Apr-24-24 12:10PM	Will TPG Inc. (TPG) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Apr-17-24 09:00AM	Sayari Closes $235 Million Strategic Investment from TPG, Inclusive of Additional Capital for Organic Growth and M&A (Business Wire)
Apr-15-24 09:02AM	How CVC Would Stack Up Against Other Publicly Traded Buyout Firms (The Wall Street Journal)
Apr-04-24 08:00AM	TPG to Announce First Quarter 2024 Financial Results and Host Investor Call (Business Wire)
Apr-03-24 08:00AM	TPG Agrees to Acquire Classic Collision (Business Wire)
Mar-29-24 01:13AM	TPG Rose 45% as Q3 Earnings Exceeded Expectations (Insider Monkey)
Mar-24-24 11:00AM	Sumitomo Life Insurance Forecasts Higher Overseas Earnings (Bloomberg)
Mar-07-24 10:05AM	Climate-Data Startup With All-Star Investors and Roots in Africa Nearly Collapses (The Wall Street Journal)
Mar-04-24 09:40AM	Salesforce, Inc. (NYSE:CRM) Q4 2024 Earnings Call Transcript (Updated) (Insider Monkey)
Mar-01-24 11:36PM	TPG Inc Director Deborah Messemer Sells 6,390 Shares (GuruFocus.com)
Feb-29-24 05:25PM	TPG Announces Pricing of Senior Notes (Business Wire)
09:19AM	Green Dot Corporation (NYSE:GDOT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 09:10PM	TPG Announces Pricing of Fixed-Rate Junior Subordinated Notes (Business Wire)
Feb-27-24 08:50AM	TPG Announces Public Offering of Senior Notes and Fixed-Rate Junior Subordinated Notes (Business Wire)
Feb-26-24 09:11AM	TPG Announces Pricing of Secondary Public Offering (Business Wire)
06:25AM	TPG Announces Launch of Secondary Public Offering (Business Wire)
Feb-21-24 09:06AM	JetBlue raised fees for checked bags earlier this month (Quartz)
Feb-20-24 01:46PM	DigitalBridge Stock Falls After the Companys Earnings Report. What Is Moving Shares. (Barrons.com)
Feb-19-24 01:16PM	TPG in Talks on 4.5 Billion Deal for Permiras Alter Domus (Bloomberg)
Feb-14-24 08:00AM	TPG to Present at the BofA Securities 2024 Financial Services Conference (Business Wire)
Feb-13-24 09:25AM	TPG Inc. (TPG) Q4 Earnings and Revenues Beat Estimates (Zacks)
08:00AM	TPG Reports Fourth Quarter and Full Year 2023 Results (Business Wire)
Feb-06-24 10:00AM	Analysts Estimate TPG Inc. (TPG) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-05-24 10:27AM	Scott Lebovitz Joins TPG as Partner to Lead TPG Rise Climate Infrastructure Investing (Business Wire)
Jan-24-24 06:32PM	3 Financial Services Stocks to Bank on for a Prosperous 2024 (InvestorPlace)
Jan-23-24 04:58PM	Top 7 Millionaire-Maker Stocks to Buy for a 10-Fold Return (InvestorPlace)
08:47AM	TPG Announces Investment in Compass Surgical Partners to Fuel Growth in Ambulatory Surgery Center Joint Ventures (Business Wire)
08:00AM	TPG to Invest in G&A Partners (Business Wire)
Jan-18-24 05:46PM	Australias Top Pension Says Buy Private Equity in Tough Times (Bloomberg)
Jan-16-24 03:48PM	TPG Acquires Supply-Chain Risk Company Sayari Labs (The Wall Street Journal)
09:00AM	TPG Announces $228 Million Strategic Growth Investment in Sayari, a Leading Counterparty & Supply Chain Risk Platform (Business Wire)
Jan-11-24 08:00AM	The Visualize Group and TPG Form Strategic Partnership (Business Wire)
Jan-10-24 08:00AM	TPG to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Investor Call (Business Wire)
Dec-27-23 07:47AM	Should You Add TPG (TPG)? (Insider Monkey)
Dec-18-23 01:24PM	TPG ACQUIRES MAJORITY OF OXFORD'S GREATER TORONTO AREA INDUSTRIAL PORTFOLIO FOR C$1 BILLION IN NEW JOINT VENTURE (PR Newswire)

TPG, Inc. operates as a global, diversified alternative asset management firm. It invests across five multi-product platforms: Capital, Growth, Impact, Real Estate, and Market Solutions. The firm aims to build dynamic products and options for its clients while also instituting discipline and operational excellence across the investment strategy and performance of its portfolio. The company was founded by Jim Coulter and David Bonderman in 1992 and is headquartered in Fort Worth, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MESSEMER DEBORAH M.	Director	Jan 14 '25	Sale	61.91	1,695	104,931	15,841	Jan 15 05:36 PM
DEBORAH M. MESSEMER	Director	Jan 14 '25	Proposed Sale	61.88	1,695	104,887		Jan 14 04:19 PM
LEGAG Partners LLC	Stockholder	Nov 15 '24	Proposed Sale	65.90	299,992	19,769,473		Nov 15 04:24 PM
MESSEMER DEBORAH M.	Director	Jul 17 '24	Sale	46.55	4,089	190,332	17,536	Jul 17 05:37 PM
MESSEMER DEBORAH M.	Director	Feb 28 '24	Sale	43.97	6,390	280,980	18,033	Mar 01 05:14 PM
Vazquez-Ubarri Anilu	Chief Operating Officer	Feb 27 '24	Option Exercise	0.00	101,937	0	435,648	Feb 29 07:23 PM
Vazquez-Ubarri Anilu	Chief Operating Officer	Feb 29 '24	Sale	41.64	101,937	4,244,657	333,711	Feb 29 07:23 PM
WINKELRIED JON	Chief Executive Officer	Feb 27 '24	Option Exercise	0.00	1,000,000	0	4,326,460	Feb 29 07:01 PM
WINKELRIED JON	Chief Executive Officer	Feb 29 '24	Sale	41.64	1,000,000	41,640,000	3,326,460	Feb 29 07:01 PM
WINKELRIED JON	Chief Executive Officer	Feb 29 '24	Sale	41.64	50,848	2,117,311	0	Feb 29 07:01 PM
Weingart Jack	Chief Financial Officer	Feb 27 '24	Option Exercise	0.00	308,468	0	1,084,450	Feb 29 06:57 PM
Weingart Jack	Chief Financial Officer	Feb 29 '24	Sale	41.64	308,468	12,844,608	775,982	Feb 29 06:57 PM
Trujillo David	Director	Feb 27 '24	Option Exercise	0.00	397,510	0	580,029	Feb 29 06:45 PM
Trujillo David	Director	Feb 29 '24	Sale	41.64	397,510	16,552,316	182,519	Feb 29 06:45 PM
Sisitsky Todd Benjamin	President	Feb 27 '24	Option Exercise	0.00	660,151	0	1,172,917	Feb 29 06:43 PM
Sisitsky Todd Benjamin	President	Feb 29 '24	Sale	41.64	660,151	27,488,688	512,766	Feb 29 06:43 PM
Sisitsky Todd Benjamin	President	Feb 29 '24	Sale	41.64	52,807	2,198,883	396,982	Feb 29 06:43 PM
Sarvananthan Ganendran	Director	Feb 27 '24	Option Exercise	0.00	162,707	0	215,093	Feb 29 06:41 PM
Sarvananthan Ganendran	Director	Feb 29 '24	Sale	41.64	172,705	7,191,436	42,388	Feb 29 06:41 PM
Rhodes Jeffrey K.	Director	Feb 27 '24	Option Exercise	0.00	408,675	0	585,167	Feb 29 06:38 PM
Rhodes Jeffrey K.	Director	Feb 29 '24	Sale	41.64	408,675	17,017,227	176,492	Feb 29 06:38 PM
Raj Nehal	Director	Feb 27 '24	Option Exercise	0.00	250,858	0	800,570	Feb 29 06:36 PM
Raj Nehal	Director	Feb 29 '24	Sale	41.64	250,858	10,445,727	549,712	Feb 29 06:36 PM
Harris Joann	Chief Compliance Officer	Feb 27 '24	Option Exercise	0.00	23,745	0	23,745	Feb 29 06:33 PM
Harris Joann	Chief Compliance Officer	Feb 29 '24	Sale	41.64	23,745	988,742	0	Feb 29 06:33 PM
Harris Joann	Chief Compliance Officer	Feb 29 '24	Sale	41.64	1,739	72,412	22,860	Feb 29 06:33 PM
Davis Kelvin L.	Director	Feb 27 '24	Option Exercise	0.00	822,017	0	1,666,601	Feb 29 06:29 PM
Davis Kelvin L.	Director	Feb 29 '24	Sale	41.64	822,017	34,228,788	844,584	Feb 29 06:29 PM
Davidson Martin	Chief Accounting Officer	Feb 27 '24	Option Exercise	0.00	39,317	0	70,308	Feb 29 06:26 PM
Davidson Martin	Chief Accounting Officer	Feb 29 '24	Sale	41.64	39,317	1,637,160	30,991	Feb 29 06:26 PM
COULTER JAMES G	Executive Chairman	Feb 27 '24	Option Exercise	0.00	1,250,000	0	1,266,949	Feb 29 06:24 PM
COULTER JAMES G	Executive Chairman	Feb 29 '24	Sale	41.64	1,334,746	55,578,823	0	Feb 29 06:24 PM
COULTER JAMES G	Executive Chairman	Feb 29 '24	Sale	41.64	16,949	705,756	386,936	Feb 29 06:24 PM
COSLET JONATHAN J	Director	Feb 27 '24	Option Exercise	0.00	1,000,000	0	1,000,000	Feb 29 06:22 PM
COSLET JONATHAN J	Director	Feb 29 '24	Sale	41.64	1,000,000	41,640,000	0	Feb 29 06:22 PM
Chorengel Maya	Director	Feb 27 '24	Option Exercise	0.00	69,298	0	131,919	Feb 29 06:20 PM
Chorengel Maya	Director	Feb 29 '24	Sale	41.64	74,773	3,113,548	57,146	Feb 29 06:20 PM
BONDERMAN DAVID	Director	Feb 27 '24	Option Exercise	0.00	1,500,000	0	1,516,949	Feb 29 06:18 PM
BONDERMAN DAVID	Director	Feb 29 '24	Sale	41.64	1,584,746	65,988,823	0	Feb 29 06:18 PM
BONDERMAN DAVID	Director	Feb 29 '24	Sale	41.64	16,949	705,756	37,967	Feb 29 06:18 PM
Berenson Bradford	General Counsel	Feb 27 '24	Option Exercise	0.00	90,895	0	287,147	Feb 29 06:15 PM
Berenson Bradford	General Counsel	Feb 29 '24	Sale	41.64	90,895	3,784,868	196,252	Feb 29 06:15 PM

Open in Screener

PYPL

PayPal Holdings Inc

Feb 21 • 04:00PM ET

74.95

Dollar change -2.68
Percentage change -3.45	%

Financial • Credit Services • USA • NASD

PYPL PayPal Holdings Inc daily Stock Chart

Peers: XYZ V MA AXP GPN ADP INTU FIS WEX

| Held by: VTI VOO QQQ SPY IVV VTV XLF FDN QQQM IWD

Index	NDX, S&P 500	P/E	18.75	EPS (ttm)	4.00	Insider Own	0.38%	Shs Outstand	993.00M	Perf Week	-2.14%
Market Cap	74.14B	Forward P/E	13.28	EPS next Y	5.64	Insider Trans	0.00%	Shs Float	985.47M	Perf Month	-16.58%
Income	4.15B	PEG	1.70	EPS next Q	1.16	Inst Own	75.15%	Short Float	2.52%	Perf Quarter	-11.48%
Sales	31.79B	P/S	2.33	EPS this Y	8.39%	Inst Trans	-1.33%	Short Ratio	2.52	Perf Half Y	4.26%
Book/sh	20.56	P/B	3.65	EPS next Y	11.98%	ROA	5.06%	Short Interest	24.85M	Perf Year	27.84%
Cash/sh	10.94	P/C	6.85	EPS next 5Y	11.01%	ROE	20.00%	52W Range	56.97 - 93.66	Perf YTD	-12.19%
Dividend Est.	-	P/FCF	10.96	EPS past 5Y	14.03%	ROI	13.40%	52W High	-19.98%	Beta	1.50
Dividend TTM	-	Quick Ratio	1.26	Sales past 5Y	12.83%	Gross Margin	40.52%	52W Low	31.56%	ATR (14)	2.32
Dividend Ex-Date	-	Current Ratio	1.26	EPS Y/Y TTM	4.45%	Oper. Margin	18.10%	RSI (14)	32.23	Volatility	2.22% 2.52%
Employees	24400	Debt/Eq	0.58	Sales Y/Y TTM	7.10%	Profit Margin	13.05%	Recom	2.13	Target Price	95.21
Option/Short	Yes / Yes	LT Debt/Eq	0.52	EPS Q/Q	-14.53%	Payout	0.00%	Rel Volume	1.53	Prev Close	77.63
Sales Surprise	1.31%	EPS Surprise	5.94%	Sales Q/Q	3.70%	Earnings	Feb 04 BMO	Avg Volume	9.85M	Price	74.95
SMA20	-8.13%	SMA50	-12.39%	SMA200	0.55%	Trades		Volume	15,118,490	Change	-3.45%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-06-25	Reiterated	Susquehanna	Positive	$94 → $101
Dec-17-24	Reiterated	Macquarie	Outperform	$95 → $115
Dec-13-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$107
Dec-09-24	Upgrade	BofA Securities	Neutral → Buy	$86 → $103
Nov-22-24	Resumed	Piper Sandler	Neutral	$88
Oct-28-24	Reiterated	Monness Crespi & Hardt	Buy	$95 → $110
Oct-14-24	Reiterated	Mizuho	Outperform	$90 → $100
Oct-10-24	Downgrade	Bernstein	Outperform → Mkt Perform	$75 → $80
Oct-01-24	Resumed	Oppenheimer	Perform
Aug-09-24	Upgrade	Daiwa Securities	Neutral → Outperform	$68 → $72
Jul-31-24	Upgrade	Bernstein	Mkt Perform → Outperform	$71 → $78
Jul-31-24	Upgrade	Argus	Hold → Buy
Jul-18-24	Downgrade	William Blair	Outperform → Mkt Perform
Jul-02-24	Upgrade	Susquehanna	Neutral → Positive	$71
Jun-24-24	Resumed	Goldman	Neutral	$69
May-31-24	Initiated	New Street	Buy	$80
May-30-24	Upgrade	Mizuho	Neutral → Buy	$68 → $90
Apr-29-24	Reiterated	Monness Crespi & Hardt	Buy	$80 → $88
Feb-13-24	Downgrade	Daiwa Securities	Outperform → Neutral	$64 → $62
Feb-09-24	Downgrade	DZ Bank	Buy → Hold	$60

Show Previous Ratings

Feb-21-25 09:00AM	Is Most-Watched Stock PayPal Holdings, Inc. (PYPL) Worth Betting on Now? (Zacks)
07:14AM	Wall St. Eyes Market Comeback for Payments Pioneer PayPal (PYPL) (TipRanks)
04:40AM	Should You Buy PayPal While It's Below $80? (Motley Fool)
Feb-19-25 08:56AM	Motley Fool Canada Analyst Gives Investors the Perspective From the North (Motley Fool)
Feb-18-25 05:58PM	Creators Insist Coupon Browser Extensions Are Stealing Their Money. Will the Courts Agree? (The Wall Street Journal)
02:09PM	Loading…
02:09PM	PayPal stock is having a rough run. Blame Apple and Shopify (Quartz)
Feb-17-25 11:40AM	PayPal, e& enterprise enter digital payments partnership (Electronic Payments)
Feb-15-25 01:32PM	Jim Cramer on PayPal Holdings, Inc. (PYPL): Theres No Real Growth There (Insider Monkey)
06:15AM	Where Will PayPal Be in 1 Year? (Motley Fool)
03:41AM	3 No-Brainer Growth Stocks to Buy With $100 Right Now (Motley Fool)
Feb-14-25 06:07AM	Prediction: 2 Stocks That'll Be Worth More Than Bank of America 10-15 Years From Now (Motley Fool)
Feb-13-25 12:00PM	Alex Karp Wants Silicon Valley to Fight for America (The Wall Street Journal)
09:21AM	Can Solana Make You a Millionaire in 2025? (Motley Fool)
05:00AM	3 Reasons to Buy PayPal Stock Like There's No Tomorrow (Motley Fool)
Feb-12-25 04:05PM	Jim Cramer On PayPal Holdings, Inc. (PYPL): Februarys Meeting Will Blow Your Socks Off! (Insider Monkey)
08:00AM	Loading…
08:00AM	Cruise into Convenience: Norwegian Cruise Line Holdings expands strategic collaboration with PayPal (PR Newswire)
Feb-11-25 10:52PM	PayPal Holdings Inc. (PYPL) Among Top 10 Unrivaled Stocks for the Next 5 Years (Insider Monkey)
07:20PM	Why Are Hedge Funds Bullish On PayPal Holdings Inc. (PYPL)? (Insider Monkey)
02:21PM	Shopify's Revenue Growth Outpaces Estimates, But PayPal-Related Margin Impact Raises Questions: Analyst (Benzinga)
09:40AM	Should Value Investors Buy PayPal (PYPL) Stock? (Zacks)
06:49AM	Should You Buy Adyen Stock While It's 50% Below Its All-Time High? (Motley Fool)
Feb-10-25 09:00AM	PayPal Holdings, Inc. (PYPL) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:39AM	How PayPal Figures In Shopify Earnings And 2025 Outlook (Investor's Business Daily)
06:04AM	PayPal dinged over branded services slow growth (Payments Dive)
Feb-08-25 06:45AM	Here Are My Top 4 Must-Own Stocks for February (Motley Fool)
Feb-07-25 02:25PM	Why PayPal Shares Plunged 13% This Week (Motley Fool)
01:54PM	How PayPals (PYPL) Stock Plunge Verifies Warren Buffetts Wisdom (TipRanks)
08:10AM	2 Top Fintech Stocks to Buy in February (Motley Fool)
04:30AM	PayPal Shares Sink Despite Upbeat Guidance. Is This a Golden Opportunity to Buy the Stock? (Motley Fool)
Feb-06-25 06:22AM	PayPal Q4 Beats Revenue and EPS Expectations, Eyes $15B Buyback (GuruFocus.com)
06:17AM	Loading…
06:17AM	Analyst Boosts PayPal Price Target to $104 Citing Robust Earnings (GuruFocus.com)
Feb-05-25 08:08AM	Why PayPal Holdings Inc. (PYPL) Went Down on Tuesday (Insider Monkey)
Feb-04-25 10:56PM	Q4 2024 PayPal Holdings Inc Earnings Call (Thomson Reuters StreetEvents) -13.17%
06:47PM	Analyst Report: PayPal Holdings, Inc. (Morningstar Research)
05:32PM	Is PayPal Holdings, Inc. (PYPL) the Best Spring Stock to Buy Now? (Insider Monkey)
05:27PM	PayPal shares plunge 12% despite earnings beat as growth slows in card processing (CNBC TV)
04:24PM	S&P 500 Gains and Losses Today: Palantir Stock Pops as Results Show AI Strength (Investopedia)
02:18PM	PayPal Transaction Margins and Payment Volume Drive Growth, Eyes 2025 Growth With Strong TMD Ahead of Investor Day: Analyst (Benzinga)
02:01PM	PayPal Stock Crashes 10.6% Despite Blowout Earnings--What's Spooking Investors? (GuruFocus.com)
01:27PM	PayPal Earnings Show Refresh Is Working. Why the Stock Is Dropping Anyway. (Barrons.com)
12:32PM	PayPal accelerates AI efforts as competition mounts (American Banker)
12:25PM	PayPal Q4: Progress, but Concerns Linger (Motley Fool)
12:01PM	PayPal Stock Tumbles As Investors Focus On Braintree Strategy (Investor's Business Daily)
11:13AM	PayPal Stock Tumbles on Lower-Than-Expected Adjusted Earnings (Investopedia)
11:11AM	Palantir skyrockets, Spotify profit, PayPal: Market Minute (Yahoo Finance Video)
11:00AM	PayPal (PYPL) Q4 2024 Earnings Call Transcript (Motley Fool)
10:53AM	PayPal shares tumble on operating margin decline (Yahoo Finance Video)
10:34AM	Why PayPal (PYPL) Stock Is Sinking Today (Insider Monkey)
09:30AM	Paypal (PYPL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:15AM	PayPal Earnings Beat. Here's Why The Stock Is Tumbling. (Investor's Business Daily)
09:04AM	PayPal Shares Drop Pre-Market as Branded Checkout Growth Misses Expectations (GuruFocus.com)
09:00AM	PayPal Q4 Earnings: Revenue And EPS Beat, Margin Pressure, $15 Billion Buyback, Outlook And More (Benzinga)
08:15AM	Paypal (PYPL) Q4 Earnings and Revenues Beat Estimates (Zacks)
07:44AM	PayPal Earnings Top Estimates, 2025 Profit Outlook Strong. But The Stock Is Tumbling. (Investor's Business Daily)
07:37AM	PayPal full-year forecast tops estimates amid shift in focus to profitable growth (Investing.com)
07:13AM	Paypal: Q4 Earnings Snapshot (Associated Press Finance)
07:09AM	PayPal's Q4 margin contraction eclipses upbeat 2025 profit forecast (Reuters)
07:09AM	PayPal forecasts 2025 profit above estimates as turnaround gains traction (Reuters)
07:00AM	PayPal Reports Fourth Quarter and Full Year 2024 Results (PR Newswire)
Feb-03-25 07:00PM	Alphabet earnings, Fed commentary, JOLTS data: What to Watch (Yahoo Finance Video)
11:39AM	Jim Cramer on PayPal Holdings, Inc. (PYPL) CEO Alex Chriss: I Think Hes Returning The Company To Solid Growth Mode (Insider Monkey)
07:03AM	UK paytech Sokin rakes in $15m from BlackRock (Electronic Payments)
Jan-31-25 09:15AM	Exploring Analyst Estimates for Paypal (PYPL) Q4 Earnings, Beyond Revenue and EPS (Zacks)
05:58AM	PayPal, Amex and Wells Fargo shake up leadership (Payments Dive)
Jan-30-25 03:41AM	The Best Value Stock to Invest $200 in Right Now (Motley Fool)
Jan-29-25 05:45PM	Paypal (PYPL) Gains As Market Dips: What You Should Know (Zacks)
05:00PM	Blockchain wont replace banks, but will improve them PayPal VP (TheStreet)
11:37AM	Xs Partnership With Visa Points Musk Back Toward Financial Roots (Barrons.com)
10:06AM	Heres What Contributed to PayPal Holdings (PYPL) Growth (Insider Monkey)
06:26AM	Crypto.com Will Suspend Tether, PayPal Stablecoin Services in Europe Due to MiCA (CoinDesk)
06:26AM	Crypto Exchanges Bitstamp, Crypto.com Suspend Some Stablecoin Services to Meet MiCA (CoinDesk)
06:26AM	Crypto Exchanges Bitstamp and Crypto.com Suspend Stablecoin Services to Meet MiCA (CoinDesk)
02:47AM	PayPals VP says stablecoin legislation needs Congress greenlightYou will see more euro-denominated..' (TheStreet)
Jan-28-25 05:48PM	P2P payments: Convenience revolution or risky business? (Electronic Payments)
04:24PM	Fashion Nova customers get $2.4 million in refunds over allegations it hid negative reviews (LA Times)
10:29AM	PayPal Earnings Are Approaching. Why Guidance Could Disappoint. (Barrons.com)
10:00AM	Paypal (PYPL) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks)
Jan-27-25 09:18PM	New York regulators fine PayPal $2m (Electronic Payments)
09:14PM	Is PayPal Stock a Buy Before Feb. 4? (Motley Fool)
01:45PM	PayPal Holdings, Inc. (PYPL): A Bull Case Theory (Insider Monkey)
09:45AM	4 Stocks That Are Too Cheap to Ignore (Motley Fool)
05:30AM	Whats New This Tax Season That Can Save You Money (The Wall Street Journal)
Jan-26-25 09:14AM	3 Stocks Down 70% or More That Could Climb Back to $100 Per Share in 2025 (Motley Fool)
03:00AM	Big Fund Sold Philip Morris, Apple, and PayPal Stock. It Bought Lululemon. (Barrons.com)
Jan-24-25 09:13PM	Trump Sends D.C.s Luxury-Home Market Into an All-Out Buying Frenzy (The Wall Street Journal)
02:40PM	Calls of the Day: Visa, Mastercard, Block, Paypal (CNBC TV)
Jan-23-25 03:34PM	PayPal steps into the future with bold stablecoin innovation (TheStreet)
09:45AM	PayPal fined by New York for cybersecurity failures (Reuters)
Jan-22-25 05:45PM	Paypal (PYPL) Rises But Trails Market: What Investors Should Know (Zacks)
01:54PM	Is PayPal Holdings (PYPL) the Best Cash App Stock to Buy According to Hedge Funds? (Insider Monkey)
09:00AM	PayPal Holdings, Inc. (PYPL) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jan-21-25 02:00PM	Trump should create a strategic bitcoin reserve: Coinbase CEO (Yahoo Finance)
07:52AM	MAGA Returns to Washington With Mood-Boosting Mocktails, Meme Coins and Paella (The Wall Street Journal)
05:10AM	Is PayPal a Millionaire Maker? (Motley Fool)
Jan-19-25 09:44AM	2 Stocks Down 32% and 71% That Could Be Big Winners in 2025 (Motley Fool)
07:30AM	The Best Fintech Stock to Invest $1,000 in Right Now (Motley Fool)
05:51AM	Here's Why PayPal Stock Is a Buy Before Feb. 3 (Motley Fool)
Jan-18-25 06:41PM	Better Fintech Stock to Buy in 2025: PayPal or Visa? (Motley Fool)
05:35AM	3 No-Brainer Fintech Stocks to Buy With $200 Right Now (Motley Fool)
04:14AM	3 No-Brainer Payments Stocks to Buy Right Now for Less Than $1,000 (Motley Fool)

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kereere Suzan	President, Global Markets	Feb 15 '25	Option Exercise	0.00	95,237	0	95,237	Feb 18 05:08 PM
Chriss James Alexander	President and CEO	Jan 15 '25	Option Exercise	0.00	23,280	0	121,343	Jan 17 05:33 PM
Scotti Diego	EVP, GM Consumer & Global Mkt	Jan 15 '25	Option Exercise	0.00	34,354	0	34,354	Jan 17 05:27 PM
Miller Jamie S	EVP, Chief Financial Officer	Dec 15 '24	Option Exercise	0.00	48,022	0	48,022	Dec 16 07:50 PM
Gill Michelle	EVP, GM, SMB & Financial Svcs	Dec 15 '24	Option Exercise	0.00	48,022	0	48,022	Dec 16 07:44 PM
Keller Frank	EVP, GM, Lg Ent & Mer Plat.	Dec 01 '24	Option Exercise	0.00	3,296	0	30,046	Dec 02 04:39 PM
Chriss James Alexander	President and CEO	Oct 15 '24	Option Exercise	0.00	176,511	0	185,384	Oct 15 05:48 PM
Keller Frank	EVP, GM, Lg Ent & Mer Plat.	Sep 01 '24	Option Exercise	0.00	3,296	0	28,386	Sep 03 07:34 PM
Keller Frank	EVP, GM, Lg Ent & Mer Plat.	Jun 01 '24	Option Exercise	0.00	3,296	0	26,726	Jun 03 09:01 PM
MESSEMER DEBORAH M.	Director	May 24 '24	Sale	61.65	4,422	272,616	13,976	May 24 05:09 PM
Keller Frank	SVP, GM, Lg Ent & Mer Plat.	Mar 01 '24	Sale	60.64	7,686	466,077	23,430	Mar 04 06:26 PM
Karczmer Aaron	EVP, Chief Enterprise Services	Mar 01 '24	Option Exercise	0.00	24,617	0	155,909	Mar 04 06:19 PM
Keller Frank	SVP, GM, Lg Ent & Mer Plat.	Mar 01 '24	Option Exercise	0.00	12,010	0	35,440	Mar 04 06:15 PM

ALLO

Allogene Therapeutics Inc

TPG

TPG Inc

PYPL

PayPal Holdings Inc

Upgrade your FINVIZ experience